在将微生物群应用于临床癌症免疫疗法的机会和挑战
Dingjiacheng Jia1, Liangjing Wang1
1Department of Gastroenterology, Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, Zhejiang Province, 310058, China; Institution of Gastroenterology, Zhejiang University, Hangzhou, Zhejiang Province, 310058, China.
肠道微生物组显著影响癌症免疫治疗的有效性. 本意见回顾了目前基于微生物的癌症治疗的临床试验和挑战,并提出了一个框架,以加快它们向患者的转化.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 微生物学 微生物学
背景情况:
- 肠道微生物群在癌症免疫疗法的有效性中起着至关重要的作用.
- 将有希望的临床前发现转化为临床应用仍然是一个重大障碍.
研究的目的:
- 为使用微生物干预用于癌症免疫治疗的当前临床试验提供见解.
- 分析设计基于微生物组的疗法的临床试验所面临的挑战.
- 提出一个框架,以加快这些策略的临床转化.
主要方法:
- 审查目前涉及便微生物种移植或特定细菌菌株的临床试验.
- 系统分析临床试验设计中的挑战 (供体选择,患者招募,程序,抗生素,安全性,终点).
主要成果:
- 很少有基于微生物组的癌症免疫疗法方法已经进入临床试验.
- 在试验设计中发现的关键挑战包括供体选择,患者招募和安全性评估.
- 提出了一个"4D"框架 (多样性,扩散,深度和细致性) 来指导未来的研究.
结论:
- 利用肠道微生物组有可能增强癌症免疫疗法.
- 解决设计挑战对于成功的临床翻译至关重要.
- 拟议的4D框架旨在加快基于微生物组的癌症治疗方法的开发.
更多相关视频
07:46Microfluidic Co-Culture Models for Dissecting the Immune Response in in vitro Tumor Microenvironments
Published on: April 30, 2021
11:02Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
Published on: October 30, 2013
相关概念视频
Tumor Immunotherapy
Microorganisms in Medicine and Therapeutics
The Tumor Microenvironment
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
